AEterna Zentaris To Present At Upcoming Canaccord Adams Life Sciences Mini-Conference In Montreal
QUEBEC CITY, Canada, May 25 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. today announced that Gilles Gagnon, President and Chief Executive Officer of the Company, will present a corporate update at the Canaccord Adams Life Sciences Mini-Conference: Drug Developers, on Wednesday, May 31, 2006, at 1:30 p.m. (local time), at the University Club in Montreal.
About AEterna Zentaris Inc.
AEterna Zentaris Inc. is a growing global biopharmaceutical company engaged in the discovery, development and marketing of therapies for cancer and endocrine disorders.
AEterna Zentaris also owns 48.29% of the equity of Atrium Biotechnologies Inc. and 64.7% of its voting rights. Atrium is a developer, manufacturer and marketer of science-based products for the cosmetics, pharmaceutical, chemical and nutritional industries.
News releases and additional information are available at
AETERNA ZENTARIS INC. (FORMERLY/ANCIENNEMENT - LES LABORATOIRES AETERNACONTACT: Media Relations: Paul Burroughs, (418) 652-8525 ext. 406,paul.burroughs@aeternazentaris.com; Investor Relations: Jenene Thomas,(418) 655-6420 or (908) 996-3154, jenene.thomas@aeternazentaris.com; Torequest a free copy of this organization's annual report, please go tohttp://www.newswire.ca and click on reports@cnw.